Gesualdo, C.; Rossi, S.; Iodice, C.M.; Guarino, F.; Petrella, M.; D’Agostino, F.A.; Perrotta, R.; Simonelli, F.
Brolucizumab Intravitreal Injections for Wet Age-Related Macular Degeneration: Real-Life Study on a Cohort of Italian Patients. Medicina 2023, 59, 1110.
https://doi.org/10.3390/medicina59061110
AMA Style
Gesualdo C, Rossi S, Iodice CM, Guarino F, Petrella M, D’Agostino FA, Perrotta R, Simonelli F.
Brolucizumab Intravitreal Injections for Wet Age-Related Macular Degeneration: Real-Life Study on a Cohort of Italian Patients. Medicina. 2023; 59(6):1110.
https://doi.org/10.3390/medicina59061110
Chicago/Turabian Style
Gesualdo, Carlo, Settimio Rossi, Clemente Maria Iodice, Francesco Guarino, Mariachiara Petrella, Fabiana Anna D’Agostino, Raffaele Perrotta, and Francesca Simonelli.
2023. "Brolucizumab Intravitreal Injections for Wet Age-Related Macular Degeneration: Real-Life Study on a Cohort of Italian Patients" Medicina 59, no. 6: 1110.
https://doi.org/10.3390/medicina59061110
APA Style
Gesualdo, C., Rossi, S., Iodice, C. M., Guarino, F., Petrella, M., D’Agostino, F. A., Perrotta, R., & Simonelli, F.
(2023). Brolucizumab Intravitreal Injections for Wet Age-Related Macular Degeneration: Real-Life Study on a Cohort of Italian Patients. Medicina, 59(6), 1110.
https://doi.org/10.3390/medicina59061110
